Stock market today: The domestic benchmark indices, Nifty 50 and Sensex, opened higher on Monday, April 27, ending a recent decline, though disappointing quarterly results from conglomerate Reliance and Axis…
Author: Admin
Paytm share price crashes 8% after RBI cancels Paytm Payments Bank License — Should you buy, sell or hold?
Shares of , parent of fintech Paytm, tumbled as much as 8% in early trade on Monday, 27 April, after the Reserve Bank of India (RBI) cancelled the license of…
Explained: Why stock markets are rising even as crude oil remains above $100
Benchmark stock market indices rallied in early trade on Monday, even as crude oil prices stayed elevated above $100, showing that investors are looking beyond immediate risks. The BSE Sensex…
Decoding Sun Pharma’s $11.75 billion deal: Why the pharma stock jumped 7% today?
Shares of Sun Pharmaceutical Industries jumped on Monday after the company announced an $11.75 billion acquisition of Organon & Co, marking one of the largest outbound deals by an Indian…
Cohance Lifesciences hits 20% upper circuit: Why the stock rising today?
Shares of Cohance Lifesciences Ltd surged 20% to Rs 432.70 on Monday, hitting the upper circuit after investors cheered a major leadership announcement. The real trigger behind today’s sharp move…
Sun Pharma shares jump over 7% after $11.75 billion Organon deal
Sun Pharmaceutical Industries (Sun Pharma) has announced the biggest acquisition in its history, agreeing to buy US-based Organon in an all-cash deal valued at $11.75 billion, including debt. The transaction…
Paytm shares tumble 6% today: Is this dip a buying chance for investors?
Shares of One 97 Communications Ltd, the parent company of Paytm, fell nearly 6% in Monday’s trade after a sharp intraday slide. The decline has naturally raised one key question…
Sensex, Nifty jump nearly 1% in early trade: Sun Pharma up 5%
Benchmark stock market indices opened higher on Monday, starting the week on a positive note. Pharma and healthcare stocks jumped in early trade on the back of Sun Phrama announcing…
Sun Pharma’s biggest-ever bet: Why markets cheered the Organon mega deal
Sun Pharmaceutical Industries has announced the biggest deal ever in Indian pharma, agreeing to buy Organon in a transaction valued at $11.75 billion. Normally, when a company unveils a debt-funded…
Cohance Lifesciences appoints former Cipla chief Umang Vohra as Executive Chairman, Group CEO
Cohance Lifesciences, a contract development and manufacturing organisation, has announced the appointment of former Cipla-Chief Executive Umang Vohra as its Executive Chairman and Group Chief Executive Officer, effective May 1, 2026.…